微量白蛋白尿及其与2型糖尿病临床特征和并发症的关系

S. Shrestha, R. Mandal, Kijan Maharjan
{"title":"微量白蛋白尿及其与2型糖尿病临床特征和并发症的关系","authors":"S. Shrestha, R. Mandal, Kijan Maharjan","doi":"10.3126/JAIM.V10I1.37088","DOIUrl":null,"url":null,"abstract":"Background and Aims: Microalbuminuria is an early marker of diabetic nephropathy, which accounts for a significant reduction in life expectancy of diabetic patients. Timely detection of microalbuminuria facilitates appropriate preventive and therapeutic approaches to minimize risks. The aim of this study is to determine the prevalence and association of microalbuminuria with clinical profile and complications of type 2 diabetes mellitus. Methods: This study was a descriptive, cross sectional study involving 100 diabetic subjects between July 2018 to January 2019 at Bir Hospital. Microalbuminuria (mg/dl) was defined as spot urine albumin to creatinine ratio of 30-300 mg/g ( Kidney Disease Improving Global Outcomes guidelines) in a single spot urine sample. Statistical analysis was done using Statistical package for the social sciences version 20. Results: Microalbuminuria was found in 35% of the sample and the rate was significantly higher among males (P =0.027). Microalbuminuria was significantly related to Body mass index (P = 0.018), duration of diabetes (P =0.000), retinopathy (P = 0.000) and stroke (P = 0.043). No statistically significant relation was found between microalbuminuria and age (P = 0.366), hypertension (P = 0.208), HbA1c (P = 0.098), dyslipidemia (P = 0.171) and ischemic heart disease (P = 0.651). Conclusions: This study shows high prevalence of microalbuminuria in Nepalese Type 2 diabetes mellitus. Screening for microalbuminuria should be done for all the type 2 diabetes mellitus patients for early detection and management of complications of diabetes mellitus. Sanjay Shrestha1*, Rajesh Kumar Mandal2, Kijan Maharjan1 1Department Of Internal Medicine, Sukraraj Tropical and Infectious Disease Hospital, Teku,Kathmandu, Nepal 2Department of Internal Medicine, Bheri Hospital, Nepalgunj, Nepal","PeriodicalId":75443,"journal":{"name":"Advances in internal medicine","volume":"10 1","pages":"29-32"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Microalbuminuria and its associations with clinical profile and complications of type 2 Diabetes Mellitus\",\"authors\":\"S. Shrestha, R. Mandal, Kijan Maharjan\",\"doi\":\"10.3126/JAIM.V10I1.37088\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and Aims: Microalbuminuria is an early marker of diabetic nephropathy, which accounts for a significant reduction in life expectancy of diabetic patients. Timely detection of microalbuminuria facilitates appropriate preventive and therapeutic approaches to minimize risks. The aim of this study is to determine the prevalence and association of microalbuminuria with clinical profile and complications of type 2 diabetes mellitus. Methods: This study was a descriptive, cross sectional study involving 100 diabetic subjects between July 2018 to January 2019 at Bir Hospital. Microalbuminuria (mg/dl) was defined as spot urine albumin to creatinine ratio of 30-300 mg/g ( Kidney Disease Improving Global Outcomes guidelines) in a single spot urine sample. Statistical analysis was done using Statistical package for the social sciences version 20. Results: Microalbuminuria was found in 35% of the sample and the rate was significantly higher among males (P =0.027). Microalbuminuria was significantly related to Body mass index (P = 0.018), duration of diabetes (P =0.000), retinopathy (P = 0.000) and stroke (P = 0.043). No statistically significant relation was found between microalbuminuria and age (P = 0.366), hypertension (P = 0.208), HbA1c (P = 0.098), dyslipidemia (P = 0.171) and ischemic heart disease (P = 0.651). Conclusions: This study shows high prevalence of microalbuminuria in Nepalese Type 2 diabetes mellitus. Screening for microalbuminuria should be done for all the type 2 diabetes mellitus patients for early detection and management of complications of diabetes mellitus. Sanjay Shrestha1*, Rajesh Kumar Mandal2, Kijan Maharjan1 1Department Of Internal Medicine, Sukraraj Tropical and Infectious Disease Hospital, Teku,Kathmandu, Nepal 2Department of Internal Medicine, Bheri Hospital, Nepalgunj, Nepal\",\"PeriodicalId\":75443,\"journal\":{\"name\":\"Advances in internal medicine\",\"volume\":\"10 1\",\"pages\":\"29-32\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in internal medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3126/JAIM.V10I1.37088\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/JAIM.V10I1.37088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

背景与目的:微量白蛋白尿是糖尿病肾病的早期标志,是糖尿病患者预期寿命显著降低的原因之一。及时发现微量白蛋白尿有助于采取适当的预防和治疗方法,以尽量减少风险。本研究的目的是确定微量白蛋白尿的患病率及其与2型糖尿病临床特征和并发症的关系。方法:本研究是一项描述性横断面研究,涉及2018年7月至2019年1月在Bir医院的100名糖尿病患者。微量白蛋白尿(mg/dl)被定义为单点尿样中尿白蛋白与肌酐比值为30- 300mg /g(肾病改善全球结局指南)。统计分析使用统计软件包为社会科学版本20。结果:微量白蛋白尿的检出率为35%,男性检出率明显高于男性(P =0.027)。微量白蛋白尿与体重指数(P = 0.018)、糖尿病病程(P =0.000)、视网膜病变(P =0.000)和卒中(P = 0.043)显著相关。微量白蛋白尿与年龄(P = 0.366)、高血压(P = 0.208)、糖化血红蛋白(P = 0.098)、血脂异常(P = 0.171)、缺血性心脏病(P = 0.651)无统计学意义。结论:本研究显示尼泊尔2型糖尿病患者微量白蛋白尿患病率较高。所有2型糖尿病患者均应进行微量白蛋白尿筛查,以便早期发现和处理糖尿病并发症。Sanjay Shrestha1*, Rajesh Kumar Mandal2, Kijan Maharjan1 1尼泊尔加德满都特库苏克拉杰热带传染病医院内科2尼泊尔加德满都Bheri医院内科
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Microalbuminuria and its associations with clinical profile and complications of type 2 Diabetes Mellitus
Background and Aims: Microalbuminuria is an early marker of diabetic nephropathy, which accounts for a significant reduction in life expectancy of diabetic patients. Timely detection of microalbuminuria facilitates appropriate preventive and therapeutic approaches to minimize risks. The aim of this study is to determine the prevalence and association of microalbuminuria with clinical profile and complications of type 2 diabetes mellitus. Methods: This study was a descriptive, cross sectional study involving 100 diabetic subjects between July 2018 to January 2019 at Bir Hospital. Microalbuminuria (mg/dl) was defined as spot urine albumin to creatinine ratio of 30-300 mg/g ( Kidney Disease Improving Global Outcomes guidelines) in a single spot urine sample. Statistical analysis was done using Statistical package for the social sciences version 20. Results: Microalbuminuria was found in 35% of the sample and the rate was significantly higher among males (P =0.027). Microalbuminuria was significantly related to Body mass index (P = 0.018), duration of diabetes (P =0.000), retinopathy (P = 0.000) and stroke (P = 0.043). No statistically significant relation was found between microalbuminuria and age (P = 0.366), hypertension (P = 0.208), HbA1c (P = 0.098), dyslipidemia (P = 0.171) and ischemic heart disease (P = 0.651). Conclusions: This study shows high prevalence of microalbuminuria in Nepalese Type 2 diabetes mellitus. Screening for microalbuminuria should be done for all the type 2 diabetes mellitus patients for early detection and management of complications of diabetes mellitus. Sanjay Shrestha1*, Rajesh Kumar Mandal2, Kijan Maharjan1 1Department Of Internal Medicine, Sukraraj Tropical and Infectious Disease Hospital, Teku,Kathmandu, Nepal 2Department of Internal Medicine, Bheri Hospital, Nepalgunj, Nepal
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信